The intersection of commercial biopharmaceutical enterprises and broader societal welfare has long remained a focal point of intense global debate. […]
Tag: industry
The Bio-Pharma Industry and Society: Reimagining the Contract Between Global Health Leaders and the Public
On March 17, 2016, the Center for Strategic and International Studies (CSIS) Global Health Policy Center hosted a pivotal symposium […]
The Bio-Pharma Industry and Society: A CSIS Dialogue on Innovation, Access, and Corporate Responsibility
On March 17, 2016, the Center for Strategic and International Studies (CSIS) Global Health Policy Center hosted a pivotal forum […]
The Bio-Pharma Industry and Society: Reimagining Global Access and Corporate Responsibility in the 21st Century
On March 17, 2016, the Center for Strategic and International Studies (CSIS) Global Health Policy Center convened a pivotal discussion […]
The Bio-Pharma Industry and Society: Reimagining the Global Compact for Health Access and Innovation
On March 17, 2016, the Center for Strategic and International Studies (CSIS) Global Health Policy Center hosted a pivotal forum […]
The Bio-Pharma Industry and Society: Reimagining the Role of Global Pharmaceutical Firms in Healthcare Access and Innovation
On March 17, 2016, the Center for Strategic and International Studies (CSIS) Global Health Policy Center convened a pivotal discussion […]
The Bio-Pharma Industry and Society: CSIS Global Health Policy Center Hosts High-Level Forum on Affordability, Innovation, and Trust
The ongoing tension between commercial viability and public health accessibility took center stage on March 17, 2016, as the Center […]
The Tech Industry Grapples with AI Doomerism As Leaders Sound the Alarm and Global Regulators Close In
The artificial intelligence sector has reached a philosophical and operational crossroads, marked by a sudden and profound shift toward existential […]
Prominent AI Safety Researcher Paul Christiano Joins OpenAI Foundation Board Amid Growing Industry Warnings Over Autonomous Model Risks
The landscape of artificial intelligence governance shifted significantly this week as Paul Christiano, one of the field’s most influential safety […]
The Bio-Pharma Industry and Society: Reimagining Global Health Access and Corporate Accountability
On March 17, 2016, the Center for Strategic and International Studies (CSIS) Global Health Policy Center convened a pivotal forum […]
